NCT01370460View on ClinicalTrials.gov

Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty

PHASE2CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Acute Blood Loss AnemiaOsteoarthritis, Knee
Interventions
DRUG

Tranexamic Acid

Topical tranexamic acid (2g/100mL 0.9% saline)

DRUG

Placebo

100mL 0.9% sterile saline

Trial Locations (1)

48202

Henry Ford Hospital, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER

NCT01370460 - Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter